不同浓度聚维酮碘稀释坐浴预防血液恶性肿瘤化疗患者肛周感染比较:随机对照试验研究方案
本研究为单中心、平行、随机对照试验,计划纳入268例有肛周感染风险的血液恶性肿瘤化疗患者,按1:1:1:1随机分为四组:肛周清洁护理对照组、1:100、1:200、1:300聚维酮碘稀释坐浴组。主要终点为住院化疗后肛周感染发生率,次要终点包括肛拭子细菌培养、感染严重程度、肛周不良事件及疼痛评分等,旨在筛选最佳浓度。
要点
- 聚维酮碘稀释坐浴预防化疗患者肛周感染的证据不足,缺乏不同浓度的随机对照试验。
- 试验设四组平行对照,主要终点为住院化疗后肛周感染发生率。
- 次要终点包括肛拭子细菌培养、感染严重程度、肛周不良事件和疼痛评分。
核心结论
- 研究假设血液恶性肿瘤化疗患者可从聚维酮碘稀释坐浴中获益,本研究将为临床医护人员提供循证建议。
研究设计与样本
- 单中心、平行、随机对照干预试验,设四个平行组,按1:1:1:1简单随机分配。
- 计划纳入268例有肛周感染风险的血液恶性肿瘤化疗患者,签署知情同意后随机分组。
- 四组分别为肛周清洁护理对照组(D组)、1:100聚维酮碘稀释坐浴组(A组)、1:200聚维酮碘稀释坐浴组(B组)、1:300聚维酮碘稀释坐浴组(C组)。
- 主要终点为住院化疗后肛周感染发生率;次要终点包括肛拭子细菌培养结果、肛周感染严重程度、肛周不良事件(干燥、脱皮、色素沉着、烧灼感)发生率、疼痛评分、住院天数及住院费用。
- 安全性评估涵盖所有与研究治疗相关的不良事件和严重不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infection is one of the most common causes of death in patients with hematological malignancies during chemotherapy. Due to its special location, local warmth and humidity, repeated pollution with stool and urine, and characteristically wrinkled anatomical structure within which bacteria can hide, the perianal becomes a site with a high incidence of infection. Such infection also has a high recurrence rate and high mortality, increasing the economic burden of patients, delaying the time of treatment and reducing the quality of life. In severe cases, sepsis occurs and endangers the patient's life. Previous studies have confirmed the effectiveness of povidone iodine (PI) in the prevention of perianal infection in patients with hematological malignancies during chemotherapy, but these reports have not documented in detail the adverse events associated with sitz bathing and the lack of randomized controlled trials of different concentrations of dilute povidone iodine sitz bathing. Therefore, the evidence is insufficient. Hence, the objective of this paper is to determine whether a povidone iodine diluent sitz bath can reduce the incidence of perianal infection compared with conventional perianal cleaning care and to observe the incidence of perianal infection, the severity of perianal infection, and the complications related to the sitz bath among groups treated with different concentrations of povidone iodine diluent, especially in high-risk patients prone to perianal infection, to screen for the optimal concentration. METHODS: The trial is designed as a single-center, parallel, randomized, controlled and intervention trial with four parallel groups, and a primary endpoint of perianal infection occurred after this hospitalization chemotherapy. Randomization will be performed as simple randomization with a 1:1:1:1 allocation. This study received full ethics committee approval. The first patient was enrolled on May 1, 2021. A total of 268 patients with hematological malignancies undergoing chemotherapy who have risk factors for perianal infection will be enrolled with informed consent and randomly allocated to one of the four arms receiving (1) perianal cleaning care (control group D), (2) 1:100 PI diluted sitz bath (intervention group A), (3) 1:200 PI diluted sitz bath (intervention group B), and (4) 1:300 PI diluted sitz bath (intervention group C). The primary endpoint of the trial was the incidence of perianal infection. The secondary endpoints of the study will be the results of anal swab bacterial culture, the severity of perianal infection, the incidence of perianal adverse events (dryness, peeling, pigmentation, burning sensation), and pain scores. The length of hospitalization in days and hospitalization expenses will be recorded. Safety will be assessed with consideration of all adverse and severe adverse events related to the study treatment. DISCUSSION: We hypothesized that patients with hematological malignancies during chemotherapy would benefit from a povidone iodine diluted sitz bath. This study will provide evidence-based recommendations for clinicians and nurses. TRIAL REGISTRATION: Chinese Clinical Trial Registry (registration ID: ChiCTR2000041073). Registered on December 17, 2020. The protocol version number is V1.0,20201217. http://www.chictr.org.cn/edit.aspx?pid=66044&htm=4.
引用
- Luo Y, Wang Y, Yang M, et al. Comparison of different concentrations of a povidone iodine-diluted sitz bath in the prevention of perianal infection in patients undergoing chemotherapy for hematological malignancy: study protocol for a randomized controlled trial. Trials. 2022. PMID: 36273160. doi:10.1186/s13063-022-06721-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。